SOPHARMA AD - Notification for sale of treasury shares

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Current report_211_treasury_shares_espi.pdfNotification for sale of treasury shares
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 211 / 2025

Date of issue: 2025-10-29

Short name of the issuer

SOPHARMA AD

Subject

Notification for sale of treasury shares

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on October 28, 2025 the Company sold 5 500 (five thousand and five hundred) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 14 925.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.71.
The total number of treasury shares after this transaction is 19 389 850 representing 3.60% of the share capital of the Company.

Annexes

File Description

Current report_211_treasury_shares_espi.pdfCurrent report_211_treasury_shares_espi.pdf Notification for sale of treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2025-10-29 Ognian Ivanov Donev Executive Director